ANKRD20A5 inhibitors are a specialized class of compounds designed to target the ANKRD20A5 protein, which contains ankyrin repeat domains responsible for mediating protein-protein interactions. ANKRD20A5 is part of the larger ankyrin repeat domain-containing protein family, known for their role in facilitating structural and functional assemblies within cellular processes. These ankyrin repeat domains form a characteristic array of helix-loop-helix structures that create specific binding interfaces for interacting with other proteins. ANKRD20A5 inhibitors work by disrupting these key interactions, preventing ANKRD20A5 from effectively participating in the formation of multi-protein complexes. This interference can alter the regulation of various cellular pathways, as ANKRD20A5 plays a role in maintaining the integrity of certain molecular assemblies.
Chemically, ANKRD20A5 inhibitors display considerable structural diversity, reflecting the need to target specific binding regions within the ankyrin repeat domains. These inhibitors may consist of small organic molecules, synthetic peptides, or even larger biologics that are designed to fit within the unique pockets or surfaces formed by the ankyrin repeats. Some inhibitors act by mimicking the natural ligands or interacting partners of ANKRD20A5, competitively binding to these critical interfaces and blocking access to the natural binding sites. Others may induce structural changes in ANKRD20A5, destabilizing the ankyrin repeat scaffold and preventing the protein from maintaining its functional conformation. By modulating the interactions mediated by ANKRD20A5, these inhibitors provide a valuable approach to understanding the protein's role in cellular organization and its involvement in various intracellular processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferases, potentially reducing methylation and altering gene expression patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can increase histone acetylation and affect gene transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
This DNA methyltransferase inhibitor might lead to hypomethylation of gene promoters. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
It inhibits histone deacetylases, potentially causing changes in gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
It binds to DNA and inhibits transcription factors, which may reduce gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it inhibits DNA methylation, affecting gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
As a histone deacetylase inhibitor, it may affect chromatin structure and gene expression. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | $110.00 | ||
This compound targets histone deacetylases, potentially impacting gene transcription. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
It is a broad histone deacetylase inhibitor that could influence gene expression patterns. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
This histone deacetylase inhibitor could alter chromatin structure and gene expression. | ||||||